Completed PHASE2 INTERVENTIONAL 2-arm NCT01902836

Efficacy Study of Dialyzed Leukocytes Extracts to Treat Paediatric Moderate Atopic Dermatitis

Efficacy of Human Dialyzed Leukocytes Extracts in Paediatrics Patients With Moderate Atopic Dermatitis.

Sponsor: Hospital Infantil de Mexico Federico Gomez

Interventions Conventional treatment plus DLE Conventional treatment plus placebo

Updated 6 times since 2017 Last updated: Jul 26, 2013 Started: Aug 31, 2011 Primary completion: Dec 31, 2012 Completion: Jan 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01902836, this PHASE2 trial focuses on Childhood Atopic Dermatitis and remains completed. Sponsored by Hospital Infantil de Mexico Federico Gomez, it has been updated 6 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Aug 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospital Infantil de Mexico Federico Gomez
Instituto de Oftalmología Fundación Conde de Valenciana
National Polytechnic Institute, Mexico

Data source: National Polytechnic Institute, Mexico

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Mexico City, Mexico